Cody J. Peer

Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer

Kevin C. Conlon, Enrico Lugli, Hugh C. Welles et al. · Journal of Clinical Oncology · 2014 · 702 citations · Full text

Life Sciences, Immunology, Oncology +17

Selumetinib in Children with Inoperable Plexiform Neurofibromas

Andrea M. Gross, Pamela L. Wolters, Eva Dombi et al. · New England Journal of Medicine · 2020 · 698 citations · Full text

Medicine, Neurology, Pediatrics +9

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

Richard Piekarz, Robin Frye, H. Miles Prince et al. · Blood · 2011 · 490 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma

Neha Korde, Mark Roschewski, Adriana Zingone et al. · JAMA Oncology · 2015 · 309 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-Escalation, Phase I Study

Jung Min Lee, Ashley Cimino‐Mathews, Cody J. Peer et al. · Journal of Clinical Oncology · 2017 · 240 citations

Medicine, Oncology, Pharmacology +17